Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

Today, the regulator revealed FDA PreCheck, which introduces a two-phase approach to getting approval for new production ...

Hundreds of adults and teenagers in England with rare eye disease Leber's hereditary optic neuropathy (LHON) will soon have ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

The move has thrilled people in the vaccine sceptic community, including Mary Holland, chief executive of Children's Health ...

If a deal is confirmed and consummated, Novartis would claim ownership of a biotech that has raised something of a stir in ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

Accelerating C-level turnover: Executives, particularly those navigating complex global portfolios, are facing unprecedented ...

When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point ...

It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to developing immunotherapies for cancer is built around dialling in to detect, and ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...